Treatment of infantile parotid hemangioma with propranolol / 中华口腔医学杂志
Chinese Journal of Stomatology
;
(12): 292-294, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-245205
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the short-term results and safety of propranolol for the treatment of infantile parotid hemangioma.</p><p><b>METHODS</b>Oral propranolol was administered to 17 infants with parotid hemangioma at a dose of 1.0-1.5 mg per kilogram of body weight per day. The patients were revisited once a week. The changes of the tumor size, texture and colour were monitored and recorded at a regular interval. The adverse effects after medication were observed and managed accordingly. The short-term results were evaluated using a 4 scales system.</p><p><b>RESULTS</b>Among the 17 patients treated, the follow-up time was 5 to 10 months. The overall response was scale I in 0 patient, scale II in 0 patients, scale III in 5 patients, and scale IV in 12 patients. No serious adverse effects were encountered.</p><p><b>CONCLUSIONS</b>Oral propranolol at a lower dose is a safe and effective method for the treatment of infantile parotid hemangioma. The short-term results were excellent and the side effects minimal.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Propranolol
/
Neoplasias de la Parótida
/
Administración Oral
/
Estudios de Seguimiento
/
Resultado del Tratamiento
/
Antagonistas Adrenérgicos beta
/
Usos Terapéuticos
/
Quimioterapia
/
Hemangioma
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Lactante
/
Masculino
Idioma:
Chino
Revista:
Chinese Journal of Stomatology
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS